Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

Title:	Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
Authors:	Callander, Natalie S.^{Aff1, IDs4140802401030w_cor1}; Silbermann, Rebecca^Aff2; Kaufman, Jonathan L.^Aff3; Godby, Kelly N.^Aff4; Laubach, Jacob^Aff5; Schmidt, Timothy M.^Aff1; Sborov, Douglas W.^Aff6; Medvedova, Eva^Aff2; Reeves, Brandi^Aff7; Dhakal, Binod^Aff8; Rodriguez, Cesar^Aff9; Chhabra, Saurabh^Aff8; Chari, Ajai^Aff9; Bal, Susan^Aff4; Anderson, Larry D.^Aff10; Dholaria, Bhagirathbhai R.^Aff11; Nathwani, Nitya^Aff12; Hari, Parameswaran^Aff8; Shah, Nina^Aff13; Bumma, Naresh^Aff14; Holstein, Sarah A.^Aff15; Costello, Caitlin^Aff16; Jakubowiak, Andrzej^Aff17; Wildes, Tanya M.^Aff15; Orlowski, Robert Z.^Aff18; Shain, Kenneth H.^Aff19; Cowan, Andrew J.^Aff20; Pei, Huiling^Aff21; Cortoos, Annelore^Aff22; Patel, Sharmila^Aff22; Lin, Thomas S.^Aff22; Giri, Smith^Aff23; Costa, Luciano J.^Aff4; Usmani, Saad Z.^{Aff24, IDs4140802401030w_cor34}; Richardson, Paul G.^Aff5; Voorhees, Peter M.^{Aff25, IDs4140802401030w_cor36}
Source:	Blood Cancer Journal. 14(1)
Database:	Springer Nature Journals